Aspirin and cancer: the emerging evidence

Trial participants who took a low-dose aspirin daily were no more likely to be diagnosed with cancer than those who took a placebo. But they did have a moderately higher risk of being diagnosed with advanced cancer and were more likely to die from advanced cancer.


 

Online statistics

Members online
2
Guests online
302
Total visitors
304

Latest posts

Back
Top